Share on StockTwits

AngioDynamics (NASDAQ:ANGO) will release its Q414 earnings data on Wednesday, July 23rd. Analysts expect AngioDynamics to post earnings of $0.12 per share and revenue of $93.65 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.

AngioDynamics (NASDAQ:ANGO) opened at 14.89 on Tuesday. AngioDynamics has a one year low of $10.84 and a one year high of $19.00. The stock’s 50-day moving average is $15.0 and its 200-day moving average is $15.34. The company has a market cap of $525.2 million and a price-to-earnings ratio of 143.86.

A number of analysts have recently weighed in on ANGO shares. Analysts at Canaccord Genuity upgraded shares of AngioDynamics from a “hold” rating to a “buy” rating in a research note on Thursday, June 19th. They now have a $20.00 price target on the stock, up previously from $16.25. On the ratings front, analysts at Zacks reiterated a “neutral” rating on shares of AngioDynamics in a research note on Thursday, May 22nd. They now have a $15.00 price target on the stock. Finally, analysts at Raymond James cut their price target on shares of AngioDynamics from $19.00 to $18.00 in a research note on Friday, May 16th.

AngioDynamics, Inc designs manufacture and sell a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.